David Roman - 25 Jul 2022 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role
President & CEO, Director
Signature
/s/ Tom Sohn as attorney-in-fact for David Roman
Issuer symbol
AFIB
Transactions as of
25 Jul 2022
Net transactions value
$0
Form type
4
Filing time
01 Aug 2022, 18:07:42 UTC
Previous filing
02 Jun 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AFIB Common Stock Award $0 +75,000 +41% $0.000000 258,355 01 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AFIB Employee Stock Options (Right to Buy) Disposed to Issuer -77,335 -61% 50,000 25 Jul 2022 Common Stock 77,335 $13.66 Direct F2
transaction AFIB Employee Stock Options (Right to Buy) Award +77,335 +155% 127,335 25 Jul 2022 Common Stock 77,335 $1.34 Direct F2
transaction AFIB Employee Stock Options (Right to Buy) Disposed to Issuer -50,000 -39% 77,335 25 Jul 2022 Common Stock 50,000 $2.41 Direct F3
transaction AFIB Employee Stock Options (Right to Buy) Award +50,000 +65% 127,335 25 Jul 2022 Common Stock 50,000 $1.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in four equal installments on each of the first four anniversaries of the vesting commencement date, subject to continued service through each such vesting date.
F2 The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F3 The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.